Small non-coding RNA and cancer

G Romano, D Veneziano, M Acunzo… - …, 2017 - academic.oup.com
The ENCODE project has reported that at least 80% of the human genome is biologically
active, yet only a small part of human DNA encodes for protein. The massive amount of RNA …

MicroRNA and cancer–a brief overview

M Acunzo, G Romano, D Wernicke… - Advances in biological …, 2015 - Elsevier
MicroRNAs (miRNAs) are short non-coding RNAs with a length of∼ 22 nucleotides,
involved in posttranscriptional regulation of gene expression. Until now, over 2588 miRNAs …

Proteogenomic characterization reveals therapeutic vulnerabilities in lung adenocarcinoma

MA Gillette, S Satpathy, S Cao, SM Dhanasekaran… - Cell, 2020 - cell.com
To explore the biology of lung adenocarcinoma (LUAD) and identify new therapeutic
opportunities, we performed comprehensive proteogenomic characterization of 110 tumors …

DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma

C Lu, Y Wei, X Wang, Z Zhang, J Yin, W Li, L Chen… - Molecular cancer, 2020 - Springer
Background Accumulating evidence shows that long noncoding RNAs (lncRNAs) are
important regulator molecules involved in diverse biological processes. Acquired drug …

Developing TRAIL/TRAIL death receptor-based cancer therapies

X Yuan, A Gajan, Q Chu, H Xiong, K Wu… - Cancer and Metastasis …, 2018 - Springer
Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is a member of the
TNF superfamily that can initiate the apoptosis pathway by binding to its associated death …

Genetics and biomarkers in personalisation of lung cancer treatment

R Rosell, TG Bivona, N Karachaliou - The Lancet, 2013 - thelancet.com
Non-small-cell lung cancer is often diagnosed at the metastatic stage, with median survival
of just 1 year. The identification of driver mutations in the epidermal growth factor receptor …

[HTML][HTML] Regulation of multidrug resistance by microRNAs in anti-cancer therapy

X An, C Sarmiento, T Tan, H Zhu - Acta Pharmaceutica Sinica B, 2017 - Elsevier
Multidrug resistance (MDR) remains a major clinical obstacle to successful cancer treatment.
Although diverse mechanisms of MDR have been well elucidated, such as dysregulation of …

A step-by-step microRNA guide to cancer development and metastasis

GS Markopoulos, E Roupakia, M Tokamani… - Cellular Oncology, 2017 - Springer
Background Cancer is one of the leading causes of mortality. The neoplastic transformation
of normal cells to cancer cells is caused by a progressive accumulation of genetic and …

The Impact of EGFR T790M Mutations and BIM mRNA Expression on Outcome in Patients with EGFR-Mutant NSCLC Treated with Erlotinib or Chemotherapy in the …

C Costa, MA Molina, A Drozdowskyj… - Clinical cancer …, 2014 - AACR
Purpose: Concomitant genetic alterations could account for transient clinical responses to
tyrosine kinase inhibitors of the EGF receptor (EGFR) in patients harboring activating EGFR …

Human umbilical cord mesenchymal stem cell-derived extracellular vesicles promote lung adenocarcinoma growth by transferring miR-410

L Dong, Y Pu, L Zhang, Q Qi, L Xu, W Li, C Wei… - Cell death & …, 2018 - nature.com
Although accumulating evidence has linked mesenchymal stem cells (MSCs) with tumor
growth, the underlying mechanisms are poorly understood. Here, we demonstrated for the …